Pre-earnings options volume in LifeMD (LFMD) is 5.6x normal with calls leading puts 22:1. Implied volatility suggests the market is ...

Craig-Hallum analyst Alex Fuhrman maintained a Buy rating on LifeMD (LFMD – Research Report) today. The company’s shares closed last Friday at ...

(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement with Gifthealth, the pharmacy ...

LifeMD (NASDAQ:LFMD) is scheduled to announce Q4 earnings results on Monday, March 10th, after market close. The consensus EPS Estimate is $0.14 (-6.7% Y/Y) and the consensus Revenue Estimate is ...

Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...

LifeMD Inc (NASDAQ:LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue ...

LifeMD, a virtual primary care services provider, said it is integrating with Gifthealth which will make Lilly's single-dose vials of Zepbound accessible to the company's eligible patients.

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

LifeMD (NASDAQ:LFMD – Get Free Report) is anticipated to announce its earnings results after the market closes on Monday, ...

Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly ...